Skip to main content
. Author manuscript; available in PMC: 2016 Aug 24.
Published in final edited form as: JAMA Pediatr. 2015 Dec;169(12):1112–1116. doi: 10.1001/jamapediatrics.2015.2831

Table 2.

Logistic regression models of maternal insulin and glucose levels in subcategories of congenital heart disease for all subjects

ToF vs. Controls
Model 1 1 Model 2 2
Analyte Crude OR (95%CI) Adjusted OR (95%CI) 2 Crude OR (95%CI) Adjusted OR (95%CI) 2
Log2(glucose) 4.83 (1.89, 12.40) 4.54 (1.71, 12.05) 8.60 (2.72, 27.24) 7.54 (2.30, 24.69)
Log2(Insulin) 0.95 (0.75, 1.19) 0.97 (0.76, 1.23) 0.74 (0.57, 0.98) 0.78 (0.59, 1.02)
dTGA vs. Controls
Model 1 Model 2
Analyte Crude OR (95%CI) Adjusted OR (95%CI)1 Crude OR (95%CI) Adjusted OR (95%CI)1
Log2(glucose) 0.68 (0.19, 2.38) 0.69 (0.19, 2.44) 1.24 (0.30, 5.07) 1.16 (0.28, 4.79)
Log2(Insulin) 0.76 (0.57, 1.02) 0.78 (0.58, 1.04) 0.75 (0.54, 1.03) 0.77 (0.56, 1.06)
1

Model 1 shows results for glucose or insulin alone. Model 2 shows results with both analytes simultaneously evaluated

2

Adjusting for maternal race/ethnicity (Hispanic, and White non-Hispanic) and maternal age at sample collection (continuous, in years).